Risk of License Renewals and Tighter Regulation
First written in FY2018. 1 of 2 entries say "Restated". Latest entry: FY2022.
The whole theme swung hardest in 2026: 4 of 7 companies on the "Worse" side.
11 other companies' latest entry also says "Restated".
- FY2022RestatedAnnual report
「The Group operates businesses requiring licenses and permits, including a Type 2 pharmaceutical manufacturing and marketing business (valid until 30 September 2026), a Type 2 medical device manufacturing and marketing business (valid until 30 September 2026), a medical device manufacturing business (valid until 30 September 2026), a cosmetics manufacturing and marketing business (valid until 18 February 2024), a pharmaceutical wholesale business (valid until 30 September 2027), and a medical device manufacturing business (valid until 18 December 2024).」
The Group specifically discloses the licenses and renewal deadlines for pharmaceuticals, medical devices, cosmetics and other products, and continues to identify renewal and regulatory tightening risks. - FY2018First statedAnnual report
「The Group operates businesses requiring licenses and permits, including a water intake permit in Yamanakako Village, a soft drink manufacturing business (valid until 31 May 2023 in Yamanashi Prefecture), a Type 2 pharmaceutical manufacturing and marketing business (valid until 3 July 2020), and a Type 2 medical device manufacturing and marketing business (valid until 20 June 2019).」
The Group lists the licenses and validity periods for water, pharmaceuticals, medical devices and cosmetics, and identifies business restrictions resulting from an inability to renew them or tighter regulations as risks.